JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheng, X. R.
Right arrow Articles by Pan, X. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheng, X. R.
Right arrow Articles by Pan, X. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 32, 22238-22242, August 6, 1999


An Iso-random Bi Bi Mechanism for Adenylate Kinase*

Xiang Rong Sheng, Xia Li, and Xian Ming PanDagger

From the National Laboratory of Biomacromolecules, Institute of Biophysics, Academia Sinica, Beijing, 100101, China

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

An iso-random Bi Bi mechanism has been proposed for adenylate kinase. In this mechanism, one of the enzyme forms can bind the substrates MgATP and AMP, whereas the other form can bind the products MgADP and ADP. In a catalytic cycle, the conformational changes of the free enzyme and the ternary complexes are the rate-limiting steps. The AP5A inhibition equations derived from this mechanism show theoretically that AP5A acts as a competitive inhibitor for the forward reaction and a mixed noncompetitive inhibitor for the backward reaction.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Adenylate kinase (AK)1 (EC 2.7.4.3) catalyzes the reaction MgATP + AMP iff  MgADP + ADP, which is essential for cell survival (1-8). This small kinase has also been considered as a "model kinase" in the study of the structure-function relationship of kinases (9). Although the catalytic kinetics of AK has been studied extensively (10-14), a full understanding mechanism is still lacking. The basic kinetic pattern is random Bi Bi (11), but whether the chemical step or the physical step(s) is rate-limiting is still controversial. Furthermore, it was reported in an early work of Kuby et al. (12) that the nature of the AP5A inhibition changes qualitatively from competitive inhibition with respect to either substrate in the forward reaction (MgATP or AMP) to noncompetitive (mixed noncompetitive) in the backward reaction with either substrate (MgADP or ADP). There is still no convincing explanation for the inhibition nature of AP5A.

In a series of previous studies in this laboratory, it was found that there are multiple native forms of AK in equilibrium in solution (15-18), which may help improve our understanding of the catalytic mechanism of AK. In this study, the catalysis and inhibition kinetics of AK was re-examined. An iso-random Bi Bi catalytic mechanism was proposed. The AP5A inhibition equations derived from this mechanism show that AP5A acts as a competitive inhibitor for the forward reaction and a mixed noncompetitive inhibitor for the backward reaction, agreeing well with experimental results.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reagents-- Pyruvate kinase, lactate dehydrogenase, glucose-6-phosphate dehydrogenase, hexokinase, phosphoenolpyruvate, NADP, NADH, AMP, ADP, ATP, and AP5A were Sigma products, and other reagents were local products of analytical grade.

Preparation and Activity Assay of Adenylate Kinase-- The enzyme was prepared essentially according to Zhang et al. (19) The yield was usually about 60 mg of pure enzyme per kilogram of rabbit muscle. The final preparation usually had a specific activity greater than 1,600 units/mg and showed only a single peak in SDS electrophoresis, gel filtration, and reversed-phase fast protein liquid chromatography. One unit is defined as 1 µmol of ADP (MgADP) generated per minute in forward reaction and 1 µmol of ATP generated per minute in backward reaction.

Methods-- UV absorbance at 340 nm was measured with either Cary 219 (Varian) or U-3000 (Hitachi, Japan) spectrophotometer.

The rate of the backward reaction (MgADP + ADP Right-arrow  MgATP + AMP) was measured by following the reduction of NADP at 340 nm in a coupled enzyme solution with hexokinase and glucose-6-phosphate dehydrogenase. The final assay mixture was: 50 mM Tris-HCl, pH 8.1, 2 mM beta -mercaptoethanol, 6.7 mM glucose, 0.67 mM NADP, 7.6 µM bovine serum albumin, 10 units/ml hexokinase, 10 units/ml glucose-6-phosphate dehydrogenase, varying and calculated concentrations of MgAc2, and ADP.

Measurements of the velocity of the forward reaction (MgATP + AMP Right-arrow  MgADP + ADP) was performed by monitoring the oxidation of NADH at 340 nm coupling with pyruvate kinase and lactate dehydrogenase. The final assay mixture was: 50 mM Tris-HCl, pH 7.5, 2 mM beta -mercaptoethanol, 75 mM KCl, 4 mM phosphoenolpyruvate, 1.0 mM of MgAc2 as free Mg2+, 0.2 mM NADH, 10 units/ml pyruvate kinase, 20 units/ml lactate dehydrogenase, 7.6 µM bovine serum albumin, plus varying and calculated amounts of MgAc2, ATP, and AMP.

Iso-random Bi Bi Mechanism-- The catalysis and inhibition mechanism of adenylate kinase is suggested as shown Scheme 1.


View larger version (18K):
[in this window]
[in a new window]
 
Scheme 1.  

Using the combined equilibrium and steady-state treatment developed by Cha (20) and described by Huang (21), Scheme 1 can be reduced to Scheme 2 and Eq. 1.
<A><AC>X</AC><AC>&cjs1171;</AC></A><SUB>1</SUB><<FR><NU>k<SUB>2</SUB>f<SUB>ME<SUB>1</SUB>T</SUB>+k<SUB>1</SUB>f<SUB>E<SUB>1</SUB></SUB></NU><DE>k<SUB><UP>−2</UP></SUB>f<SUB>D<SUB>1</SUB>E<SUB>2</SUB>D<SUB>2</SUB></SUB>+k<SUB><UP>−</UP>1</SUB>f<SUB>E<SUB>2</SUB></SUB></DE></FR>><A><AC>X</AC><AC>&cjs1171;</AC></A><SUB>2</SUB>
<UP><SC>Scheme 2</SC></UP>

Here E1 and E2 denote two native forms of enzyme, one form (E1) can bind with AMP (M) and MgATP (T), and the other one with ADP (D1) and MgADP (D2). Both interconversions of the ternary complexes and free enzymes are rate-limiting steps. This mechanism is, in principle, a random Bi Bi type, similar to that proposed by an earlier study (11), but with the major modification that two native forms of enzyme are introduced. This mechanism is based on the fact that AK undergoes large domain movements upon substrate binding (22). After aligning 17 known structures of nucleoside monophosphate kinases, Vonrhein et al. (23) gave movies to demonstrate the catalytic cycle of AK, which showed that the conformation of ternary complex of enzyme binding with AMP and ATP is different from that of enzyme binding with two ADP. That is to say, AK undergoes at least two steps of conformational changes. One step is the change of a ternary complex with bound substrates to one with bound products during the reaction, and the other is the change of the free enzyme in different forms. These conformational changes should be the rate-limiting steps in the catalytic cycle of AK, whereas the binding of substrates to and the release of products from the enzyme are quickly equilibrated. AP5A is composed of ATP and AMP connected by a fifth phosphate, and mimics both substrates (24). It was assumed that AP5A (I) can only bind to E1 and the binding reaction of E1 with AP5A is rapid with an equilibrium constant of KI. We have also assumed that the affinities for substrates of free enzyme and binary complexes, ME1 and E1T, as well as D1E2 and E2D1, are the same.

<FR><NU>v</NU><DE>E<SUB>0</SUB></DE></FR>=<FR><NU>k<SUB>2</SUB>f<SUB>ME<SUB>1</SUB>T</SUB><A><AC>X</AC><AC>&cjs1171;</AC></A><SUB>1</SUB>−k<SUB><UP>−</UP>2</SUB>f<SUB>D<SUB>1</SUB>E<SUB>2</SUB>D<SUB>2</SUB></SUB><A><AC>X</AC><AC>&cjs1171;</AC></A><SUB>2</SUB></NU><DE><A><AC>X</AC><AC>&cjs1171;</AC></A><SUB>1</SUB>+<A><AC>X</AC><AC>&cjs1171;</AC></A><SUB>2</SUB></DE></FR> (Eq. 1)
=<FR><NU>k<SUB>2</SUB>f<SUB>ME<SUB>1</SUB>T</SUB>k<SUB><UP>−</UP>1</SUB>f<SUB>E<SUB>2</SUB></SUB>−k<SUB><UP>−</UP>2</SUB>f<SUB>D<SUB>1</SUB>E<SUB>2</SUB>D<SUB>2</SUB></SUB>k<SUB>1</SUB>f<SUB>E<SUB>1</SUB></SUB></NU><DE>k<SUB><UP>−</UP>2</SUB>f<SUB>D<SUB>1</SUB>E<SUB>2</SUB>D<SUB>2</SUB></SUB>+k<SUB><UP>−</UP>1</SUB>f<SUB>E<SUB>2</SUB></SUB>+k<SUB>2</SUB>f<SUB>ME<SUB>1</SUB>T</SUB>+k<SUB>1</SUB>f<SUB>E<SUB>1</SUB></SUB></DE></FR>
= <FR><NU><FR><NU>k<SUB>2</SUB>k<SUB><UP>−</UP>1</SUB>[M][T]</NU><DE>K<SUB>M</SUB>K<SUB>T</SUB></DE></FR>−<FR><NU>k<SUB><UP>−</UP>2</SUB>k<SUB>1</SUB>[D<SUB>1</SUB>][D<SUB>2</SUB>]</NU><DE>K<SUB>D1</SUB>K<SUB>D2</SUB></DE></FR></NU><DE><FENCE>k<SUB><UP>−</UP>1</SUB>+k<SUB><UP>−</UP>2</SUB><FR><NU>[D<SUB>1</SUB>][D<SUB>2</SUB>]</NU><DE>K<SUB>D1</SUB>K<SUB>D2</SUB></DE></FR></FENCE><FENCE>1+<FENCE><FR><NU>1</NU><DE>K<SUB>M</SUB></DE></FR>+<FR><NU>1</NU><DE>K′<SUB>M</SUB></DE></FR></FENCE>[M]+<FR><NU>[T]</NU><DE>K<SUB>T</SUB></DE></FR>+<FR><NU>[M][T]</NU><DE>K<SUB>M</SUB>K<SUB>T</SUB></DE></FR>+<FR><NU>[I]</NU><DE>K<SUB>I</SUB></DE></FR></FENCE>+<FENCE>k<SUB>1</SUB>+k<SUB>2</SUB><FR><NU>[M][T]</NU><DE>K<SUB>M</SUB>K<SUB>T</SUB></DE></FR></FENCE><FENCE>1+<FENCE><FR><NU>1</NU><DE>K<SUB>D1</SUB></DE></FR>+<FR><NU>1</NU><DE>K′<SUB>D1</SUB></DE></FR></FENCE>[D<SUB>1</SUB>]+<FR><NU>[D<SUB>2</SUB>]</NU><DE>K<SUB>D2</SUB></DE></FR>+<FR><NU>[D<SUB>1</SUB>][D<SUB>2</SUB>]</NU><DE>K<SUB>D1</SUB>K<SUB>D2</SUB></DE></FR></FENCE></DE></FR>
In the forward reaction, one binding site is specific for AMP, whereas the other less specific one is for MgATP (25), so the reaction system consists of free enzymes E1 and E2, binary complexes ME1, E1M, and E1T and ternary complexes ME1T and ME1M. The products, D1 and D2, are rapidly removed by the coupled enzymes, so that the concentration of ternary complex D1E1D2 approaches zero.

In the absence of AP5A, we have Eq. 2.
<FR><NU>v</NU><DE>E<SUB>0</SUB></DE></FR>=<FR><NU>2<FR><NU>k<SUB>2</SUB>k<SUB><UP>−</UP>1</SUB>[M][T]</NU><DE>K<SUB>M</SUB>K<SUB>T</SUB></DE></FR></NU><DE>k<SUB><UP>−</UP>1</SUB><FENCE>1+<FENCE><FR><NU>1</NU><DE>K<SUB>M</SUB></DE></FR>+<FR><NU>1</NU><DE>K′<SUB>M</SUB></DE></FR></FENCE>[M]+<FR><NU>[T]</NU><DE>K<SUB>T</SUB></DE></FR>+<FR><NU>[M][T]</NU><DE>K<SUB>M</SUB>K<SUB>T</SUB></DE></FR></FENCE>+k<SUB>1</SUB>+k<SUB>2</SUB><FR><NU>[M][T]</NU><DE>K<SUB>M</SUB>K<SUB>T</SUB></DE></FR></DE></FR> (Eq. 2)

Here a factor of two is introduced, because the forward reaction produces two ADP molecules.

In the presence of AP5A, we have Eq. 3.
<FR><NU>v</NU><DE>E<SUB>0</SUB></DE></FR>=<FR><NU>2<FR><NU>k<SUB>2</SUB>k<SUB><UP>−</UP>1</SUB>[M][T]</NU><DE>K<SUB>M</SUB>K<SUB>T</SUB></DE></FR></NU><DE>k<SUB><UP>−</UP>1</SUB><FENCE>1+<FENCE><FR><NU>1</NU><DE>K<SUB>M</SUB></DE></FR>+<FR><NU>1</NU><DE>K′<SUB>M</SUB></DE></FR></FENCE>[M]+<FR><NU>[T]</NU><DE>K<SUB>T</SUB></DE></FR>+<FR><NU>[M][T]</NU><DE>K<SUB>M</SUB>K<SUB>T</SUB></DE></FR>+<FR><NU>[I]</NU><DE>K<SUB>T</SUB></DE></FR></FENCE>+k<SUB>1</SUB>+k<SUB>2</SUB><FR><NU>[M][T]</NU><DE>K<SUB>M</SUB>K<SUB>T</SUB></DE></FR></DE></FR> (Eq. 3)

Eq. 3 shows that AP5A acts as a competitive inhibitor for the forward reaction.

In the backward reaction, one binding site is specific for ADP, and the other less specific one for MgADP (25), so the reaction system consists of free enzymes E1 and E2, binary complexes D1E2, E2D1, and E2D2, as well as ternary complexes D1E2D2 and D1E2D1. The product ATP is rapidly removed by coupled enzymes, so that the concentration of ternary complex ME1T approaches zero. The product conversion was controlled under 10%, and the concentration of binary complex ME1 could be considered as zero.

In the absence of AP5A, we have Eq. 4.
<FR><NU>v</NU><DE>E<SUB>0</SUB></DE></FR>=<FR><NU><FR><NU>k<SUB><UP>−</UP>2</SUB>k<SUB>1</SUB>[D<SUB>1</SUB>][D<SUB>2</SUB>]</NU><DE>K<SUB>D1</SUB>K<SUB>D2</SUB></DE></FR></NU><DE>k<SUB><UP>−</UP>1</SUB>+k<SUB><UP>−</UP>2</SUB><FR><NU>[D<SUB>1</SUB>][D<SUB>2</SUB>]</NU><DE>K<SUB>D1</SUB>K<SUB>D2</SUB></DE></FR>+k<SUB>1</SUB><FENCE>1+<FENCE><FR><NU>1</NU><DE>K<SUB>D1</SUB></DE></FR>+<FR><NU>1</NU><DE>K′<SUB>D1</SUB></DE></FR></FENCE>[D<SUB>1</SUB>]+<FR><NU>[D<SUB>2</SUB>]</NU><DE>K<SUB>D2</SUB></DE></FR>+<FR><NU>[D<SUB>1</SUB>][D<SUB>2</SUB>]</NU><DE>K<SUB>D1</SUB>K<SUB>D2</SUB></DE></FR></FENCE></DE></FR> (Eq. 4)

The free concentrations of ADP ([D1]) and MgADP ([D2]) can be calculated from the total concentrations of ADP ([D1]0)and Mg ([Mg]0) by Eqs. 5 and 6.
[D<SUB>2</SUB>]=<FR><NU><FR><NU>1</NU><DE>K<SUB>Mg</SUB></DE></FR>+[D<SUB>1</SUB>]<SUB>0</SUB>+[Mg]<SUB>0</SUB>−<RAD><RCD><FENCE><FR><NU>1</NU><DE>K<SUB>Mg</SUB></DE></FR>+[D<SUB>1</SUB>]<SUB>0</SUB>+[Mg]<SUB>0</SUB></FENCE><SUP>2</SUP>−4×[D<SUB>1</SUB>]<SUB>0</SUB>[Mg]<SUB>0</SUB></RCD></RAD></NU><DE>2</DE></FR> (Eq. 5)
[D<SUB>1</SUB>]=[D<SUB>1</SUB>]<SUB>0</SUB>−[D<SUB>2</SUB>] (Eq. 6)

The stability constant KMg = 2,500 M-1 was used in the calculation (26).

In the presence of AP5A, we have Eq. 7.
<FR><NU>v</NU><DE>E<SUB>0</SUB></DE></FR>=<FR><NU><FR><NU>k<SUB><UP>−</UP>2</SUB>k<SUB>1</SUB>[D<SUB>1</SUB>][D<SUB>2</SUB>]</NU><DE>K<SUB>D1</SUB>K<SUB>D2</SUB></DE></FR></NU><DE><AR><R><C><FENCE>k<SUB><UP>−</UP>1</SUB>+k<SUB><UP>−</UP>2</SUB><FR><NU>[D<SUB>1</SUB>][D<SUB>2</SUB>]</NU><DE>K<SUB>D1</SUB>K<SUB>D2</SUB></DE></FR></FENCE><FENCE>1+<FR><NU>[I]</NU><DE>K<SUB>I</SUB></DE></FR></FENCE></C></R><R><C>+k<SUB>1</SUB><FENCE>1+<FENCE><FR><NU>1</NU><DE>K<SUB>D1</SUB></DE></FR>+<FR><NU>1</NU><DE>K′<SUB>D1</SUB></DE></FR></FENCE>[D<SUB>1</SUB>]+<FR><NU>[D<SUB>2</SUB>]</NU><DE>K<SUB>D2</SUB></DE></FR>+<FR><NU>[D<SUB>1</SUB>][D<SUB>2</SUB>]</NU><DE>K<SUB>D1</SUB>K<SUB>D2</SUB></DE></FR></FENCE></C></R></AR></DE></FR> (Eq. 7)

Eq. 7 shows that AP5A acts as a mixed noncompetitive inhibitor for backward reaction.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Catalytic Patterns-- Fig. 1, A and B, shows the catalytic pattern when AMP and ATP were used as substrates of the forward reaction with the concentration of magnesium ion kept constant at 1 mM. Fig. 1A shows AMP as the variable substrate, whereas Fig. 1B shows MgATP as the variable substrate. With MgATP concentration lower than 0.1 mM, the specific activity increases initially then decreases with increasing concentration of AMP, implying that AMP can bind to the MgATP site (Fig. 1A).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Catalytic pattern of adenylate kinase at pH 7.4 in the forward reaction. The free magnesium ion concentration was kept constant at 1 mM. A, AMP as variable substrate at various fixed MgATP concentrations as indicated; B, MgATP as variable substrate at various fixed AMP concentrations as indicated. In all experiments, the final concentration of adenylate kinase was 2.3 nM unless otherwise specified.

In the backward reaction, the concentrations of ADP and MgADP are dependent on the concentration of magnesium ion. The kinetic measurements were carried out under either varied concentrations of magnesium ion with constant ADP (Fig. 2A) or varied concentrations of ADP with constant magnesium ion (Fig. 2B). Fig. 2A shows that when ADP concentration is lower than 0.5 mM, the specific activity increases first then decreases with the increasing concentration of magnesium ion, because the concentration of MgADP increases with the increasing of magnesium ion concentration, whereas that of ADP decreases. Fig. 2B shows that with magnesium ion concentration lower than 0.5 mM, the specific activity increases first then decreases with increasing ADP concentrations, implying that ADP can bind to the MgADP site.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   Catalytic pattern of adenylate kinase at pH 8.1 in the backward reaction. A, magnesium ion as variable substrate at various fixed ADP concentrations as indicated; B, ADP as variable substrate at various fixed magnesium ion concentrations as indicated.

The full set of data in Figs. 1 and 2 was fitted to Eqs. 2 and 4 to calculate kinetic parameters by a computer program. The best fit kinetic parameters are summarized in Table I and were used to draw the solid lines in Figs. 1 and 2, which are in good agreement with the experimental results.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Kinetic parameters of adenylate kinase
The Michaelis constants Km equal to the dissociation constants, i.e. Km(AMP) = KM, Km(MgATP) = KT, Km(ADP) = KD1, Km(MgADP) = KD2, Ki(ADP) = K'D1, Ki(AP5A) = KI, and Ki(AMP) = K'M.

AP5A Inhibition Patterns-- It has been reported by Kuby et al. (12) that AP5A acts as a competitive inhibitor for the forward reaction and a noncompetitive inhibitor (the origin figures show a mixed noncompetitive) for the backward reaction, here the AP5A inhibition patterns were re-examined.

Because the affinities of AMP to MgATP site as well as ADP to MgADP site are relatively smaller, Eqs. 10 and 12 can be treated as linear. Fig. 3, A and B, shows the AP5A inhibition patterns in the forward reaction with varied AMP (Fig. 3A) and MgATP (Fig. 3B) concentrations, respectively, indicating that AP5A acts as a competitive inhibitor for the forward reaction.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Inhibition pattern of AP5A in the forward reaction. A, the MgATP concentration was kept constant at 0.05 mM, and AMP as variable substrate at various fixed AP5A concentrations as indicated; B, the AMP concentration was kept at 0.1 mM, and MgATP as variable substrate at various fixed AP5A concentrations as indicated.

Fig. 4, A and B, shows the AP5A inhibition patterns in the backward reaction with varied ADP (Fig. 4A) and MgADP (Fig. 4B) concentrations calculated according to Eqs. 3 and 7, respectively, exhibiting that AP5A acts as a mixed noncompetitive inhibitor for the backward reaction.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Inhibition pattern of AP5A in the backward reaction. A, the MgADP concentration was kept at 0.1 mM, and ADP as variable substrate at various fixed AP5A concentrations as indicated; B, the ADP concentration was kept at 0.03 mM, and ADP as variable substrate at various fixed AP5A concentrations as indicated.

A value of KI = 2 ± 0.5 × 10-6 mM was obtained from the full set of data in Figs. 3 and 4.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

There are two nucleotide-binding sites of AK, one for the magnesium complexes and the other for uncomplexed nucleotides. X-ray and NMR studies suggested that the latter substrate site is more specific, whereas the former can bind uncomplexed substrates to some extent (24). The above experiments demonstrate that AMP or ADP shows substrate inhibition in the forward or the backward reaction, respectively. This result, which was also observed in bakers' yeast AK by Russell and co-workers (25), is in agreement with the x-ray and NMR findings.

The equilibrium concentrations of E1 and E2 in the absence of substrates should be different from those at steady state, so a lag (or burst) phase should occur in the beginning of the catalytic reaction. However, because the activity of AK was assayed with a coupled enzyme system, the initial process is too complicated to follow.

The fact that AP5A acts as a competitive inhibitor for the forward reaction and a mixed noncompetitive inhibitor for the backward reaction cannot be explained by the normal random Bi Bi mechanism. However, these inhibition patterns are consistent with an iso-random Bi Bi mechanism in which the substrates can bind to one isoform while the products bind to another isoform of the enzyme. This strongly supports the suggestion that two native forms of AK might be involved in the catalytic reactions.

The rate of enzyme conformational changes is on the order of 102 s-1 in the catalytic reactions, which is much higher than that determined by ANS fluorescence probe (about 10-2 s-1, see Ref. 15). This perhaps can be explained that substrates decrease whereas ANS increases the activation energy of enzyme conformational changes. It was indeed observed that ANS inhibits the folding of AK, whereas AMP, ADP, and ATP can accelerate the folding (16). Another possibility is that the two native forms involved in the catalytic cycle are different from those distinguished by ANS probe, and AK might exist in more native forms in equilibrium. The current experimental results provide no information to distinguish the above possibilities.

It has been reported that some proteins may exist in more than one distinct folded form in equilibrium. Evidence for distinguishing multiple native forms of staphylococcal nuclease has come from electrophoresis and NMR studies (27-32). For calbindin D9K, the evidence of multiple forms has come from not only NMR studies but also from x-ray crystal structures (33, 34). These results shed light on the understanding of the protein folding problem but give little information on the biological role of the multiple native forms. Is the multiple native forms are necessary for protein to perform its biological functions or only the results of protein folding? Our results suggest that the multiple native forms are necessary for AK to perform its catalytic function. AK, a small nucleoside monophosphate kinase, undergoes large domain movements during catalysis (23), because it has to shield its active center from water to avoid ATP hydrolysis. Because the folded forms of AK must be flexible, multiple native forms with small free energy difference can exist in equilibrium in the absence of substrates.

In summary, two rate-limiting steps are involved in the catalytic cycle of AK. Only one form (E1) of AK can bind with AP5A, so AP5A acts as a competitive inhibitor for the forward reaction and a noncompetitive inhibitor for the backward reaction.

    ACKNOWLEDGEMENTS

We express our sincere thanks to Prof. C. L. Tsou of this institution for reading the manuscript.

    FOOTNOTES

* This work was supported in part by Grants 39625008 and 39670157 from the National Natural Science Foundation of China and the Pandeng Project of the China Commission for Science and Technology.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: National Laboratory of Biomacromolecules, Institute of Biophysics, Academia Sinica, 15 Datun Rd., Beijing 100101, China. Tel.: 86-10-6488-8497; Fax: 86-10-6487-2026; E-mail: xmpan@sun5.ibp.ac.cn.

    ABBREVIATIONS

The abbreviations used are: AK, adenylate kinase; ANS, 1-anilino-8-naphthalenesulfonate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Noda, L. (1973) in The Enzymes (Boyer, P. D., ed), Vol. 8 , pp. 279-305, Academic Press, New York
2. Atkinson, D. E. (1977) Cellular Energy Metabolism and Its Regulation , pp. 85-107, Academic Press, Orlando, FL
3. Hamada, M., Sumida, M., Kurokawa, Y., Sunayashiki-Kusuzaki, K., Okuda, H., Watanabe, T., and Kuby, S. A. (1985) J. Biol. Chem. 260, 11595-11602[Abstract/Free Full Text]
4. Miwa, S., Fujii, H., Tani, K., Takahashi, K., Tanizawa, T., and Igarashi, T. (1983) Am. J. Hematol. 14, 325-333[Medline] [Order article via Infotrieve]
5. Matsuura, S., Igarashi, M., Tanizawa, Y., Yamada, M., Kishi, F., Kajii, T., Fujii, H., Miwa, S., Sakurai, M., and Nakazawa, A. (1989) J. Biol. Chem. 264, 10148-10155[Abstract/Free Full Text]
6. Toren, A., Brok-Simoni, F., Ben-Bassat, I., Holtzman, F., Mandel, M., Neumann, Y., and Ramot, B. (1994) Br. J. Haematol. 87, 376-380[Medline] [Order article via Infotrieve]
7. Qualtieri, A., Pedace, V., Bisconte, M. G., Bria, M., Gulino, B., Andreoli, V., and Brancati, C. (1997) Br. J. Haematol. 99, 770-776[CrossRef][Medline] [Order article via Infotrieve]
8. Thomas, G., and Murthy, W. (1997) J. Clin. Lab. Anal. 11, 351-356[CrossRef][Medline] [Order article via Infotrieve]
9. Tsai, M.-D., and Yan, H. G. (1991) Biochemistry 30, 6806-6818[CrossRef][Medline] [Order article via Infotrieve]
10. Callaghan, O. H., and Weber, G. (1959) Biochem. J. 73, 473-485[Medline] [Order article via Infotrieve]
11. Rhoads, D. G., and Lowenstein, J. M. (1968) J. Biol. Chem. 243, 3963-3972[Abstract/Free Full Text]
12. Kuby, S. A., Hamada, M., Gerber, D., Tsai, W. C., Jacobs, H. K., Cress, MC., Chua, G. K., Fleming, G., Wu, L. H., Fischer, A. H., Frischat, A., and Maland, L. (1978) Arch. Biochem. Biophys. 187, 34-52[CrossRef][Medline] [Order article via Infotrieve]
13. Hamada, M., and Kuby, S. A. (1978) Arch. Biochem. Biophys. 190, 772-792[CrossRef][Medline] [Order article via Infotrieve]
14. Hamada, M., Paimieri, R. H., Russell, G. A., and Kuby, S. A. (1979) Arch. Biochem. Biophys. 195, 155-177[CrossRef][Medline] [Order article via Infotrieve]
15. Zhang, H. J., Sheng, X. R., Niu, W. D., Pan, X. M., and Zhou, J. M. (1998) J. Biol. Chem. 273, 7448-7456[Abstract/Free Full Text]
16. Zhang, H. J., Sheng, X. R., Pan, X. M., and Zhou, J. M. (1998) Biochem. J. 333, 401-405
17. Sheng, X. R., Zhang, H. J., Pan, X. M., and Zhou, J. M. (1997) FEBS Lett. 413, 429-432[CrossRef][Medline] [Order article via Infotrieve]
18. Zhang, H. J., Sheng, X. R., Pan, X. M., and Zhou, J. M. (1997) Biochem. Biophys. Res. Commun. 238, 382-386[CrossRef][Medline] [Order article via Infotrieve]
19. Zhang, Y. L., Zhou, J. M., and Tsou, C. L. (1993) Biochim. Biophys. Acta 1164, 61-67[CrossRef][Medline] [Order article via Infotrieve]
20. Cha, S. (1968) J. Biol. Chem. 243, 820-825[Abstract/Free Full Text]
21. Huang, C. Y. (1979) in Methods in Enzymology (Purich, D. L., ed), Vol. 63 , pp. 54-84, Academic Press, New York
22. Schulz, G. E., Müller, C. W., and Diederich, K. (1990) J. Mol. Biol. 213, 627-630[CrossRef][Medline] [Order article via Infotrieve]
23. Vonrhein, C., Schlauderer, G. J., and Schulz, G. E. (1995) Structure 3, 483-490[Medline] [Order article via Infotrieve]
24. Lienhard, G. E., and Secemski, I. I. (1973) J. Biol. Chem. 248, 1121-1123[Abstract/Free Full Text]
25. Khoo, J. C., and Russell, P. J., Jr. (1970) J. Biol. Chem. 245, 4163-4167[Abstract/Free Full Text]
26. Kuby, S. A., and Noltman, E. A. (1962) in The Enzymes (Boyer, P. D. , Lardy, H. A. , and Myrback, K., eds), Ed. 2, Vol. 6 , pp. 515-603, Academic Press, New York
27. Taniuchi, H., and Anfinsen, C. B. (1966) J. Biol. Chem. 241, 4366-4385[Abstract/Free Full Text]
28. Markley, J. L., Williams, M. N., and Jardetzky, O. (1970) Proc. Natl. Acad. Sci. U. S. A. 65, 645-651[Abstract/Free Full Text]
29. Arata, Y., Khalifah, R., and Jardetzky, O. (1973) Ann. N. Y. Acad. Sci. 222, 230-239[CrossRef][Medline] [Order article via Infotrieve]
30. Tucker, P. W., Hazen, E. E., and Cotton, F. A. (1978) Mol. Cell. Biochem. 22, 67-77[CrossRef][Medline] [Order article via Infotrieve]
31. Evans, P. A., Dobson, C. M., Kautz, R. A., Hatfull, G., and Fox, R. O. (1987) Nature 329, 266-268[CrossRef][Medline] [Order article via Infotrieve]
32. Evans, P. A., Kautz, R. A., Fox, R. O., and Dobson, C. M. (1989) Biochemistry 28, 362-370[CrossRef][Medline] [Order article via Infotrieve]
33. Chazin, W. J., Kördel, J., Drakenberg, T., Thulin, E., Hofmann, T., and Forsén, S. (1989) Proc. Natl. Acad. Sci., U. S. A. 86, 2195-2198[Abstract/Free Full Text]
34. Svensson, L. A., Thulin, E., and Forsén, S. (1992) J. Mol. Biol. 223, 601-606[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Arora and C. L. Brooks III
Large-scale allosteric conformational transitions of adenylate kinase appear to involve a population-shift mechanism
PNAS, November 20, 2007; 104(47): 18496 - 18501.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
M. Bellinzoni, A. Haouz, M. Grana, H. Munier-Lehmann, W. Shepard, and P. M. Alzari
The crystal structure of Mycobacterium tuberculosis adenylate kinase in complex with two molecules of ADP and Mg2+ supports an associative mechanism for phosphoryl transfer
Protein Sci., June 1, 2006; 15(6): 1489 - 1493.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Castellanos, D. B. Wilson, and M. L. Shuler
A modular minimal cell model: Purine and pyrimidine transport and metabolism
PNAS, April 27, 2004; 101(17): 6681 - 6686.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Haouz, V. Vanheusden, H. Munier-Lehmann, M. Froeyen, P. Herdewijn, S. Van Calenbergh, and M. Delarue
Enzymatic and Structural Analysis of Inhibitors Designed against Mycobacterium tuberculosis Thymidylate Kinase. NEW INSIGHTS INTO THE PHOSPHORYL TRANSFER MECHANISM
J. Biol. Chem., February 7, 2003; 278(7): 4963 - 4971.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. B. Roman, R. A. Meyer, and R. W. Wiseman
Phosphocreatine kinetics at the onset of contractions in skeletal muscle of MM creatine kinase knockout mice
Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1776 - C1783.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
A. Markaryan, O. Zaborina, V. Punj, and A. M. Chakrabarty
Adenylate Kinase as a Virulence Factor of Pseudomonas aeruginosa
J. Bacteriol., June 1, 2001; 183(11): 3345 - 3352.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheng, X. R.
Right arrow Articles by Pan, X. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheng, X. R.
Right arrow Articles by Pan, X. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.